Results 261 to 270 of about 2,285,924 (374)

Sideroblastogram in patients with myelodysplastic syndrome

, 1994
Kensuke Kojima
openalex   +2 more sources

Use of human recombinant erythropoietin and prednisone for treatment of myelodysplastic syndrome with erythroid predominance in a dog [PDF]

, 1998
Laura Boone, Kenneth W. Knauer, Steve W. Rapp, Jerry F. Stewart, Jaime F. Modiano   +4 more
openalex   +1 more source

Autoimmune manifestations associated with myelodysplastic syndromes

Annals of Hematology, 2018
E. Grignano, V. Jachiet, P. Fenaux, L. Adès, O. Fain, A. Mékinian   +5 more
semanticscholar   +1 more source

Treatment of lower-risk myelodysplastic syndromes. [PDF]

Haematologica
Merz AMA, Platzbecker U.
europepmc   +1 more source

Concurrent Inflammatory Bowel Disease and Myelodysplastic Syndromes

, 1999
Gavin C. Harewood, Edward V. Loftus, Ayalew Tefferi, William J. Tremaine, William J. Sandborn   +4 more
openalex   +1 more source

Myelodysplastic syndrome with vasculitic manifestations [PDF]

, 1997
A. Pirayesh, Robert J. A. M. Verbunt, Ph. M. Kluin, A. Edo Meinders, Paul H. E. Meijer   +4 more
openalex   +1 more source

Dynamics of clonal evolution in myelodysplastic syndromes

Nature Genetics, 2016
H. Makishima, T. Yoshizato, Kenichi Yoshida, M. Sekeres, T. Radivoyevitch, Hiromichi Suzuki, B. Przychodzen, Y. Nagata, M. Meggendorfer, M. Sanada, Y. Okuno, C. Hirsch, T. Kuzmanovic, Yusuke Sato, A. Sato-Otsubo, T. LaFramboise, N. Hosono, Y. Shiraishi, K. Chiba, C. Haferlach, W. Kern, Hiroko Tanaka, Y. Shiozawa, I. Gómez-Seguí, Holleh Husseinzadeh, Swapna Thota, K. Guinta, B. Dienes, T. Nakamaki, S. Miyawaki, Y. Saunthararajah, S. Chiba, S. Miyano, L. Shih, T. Haferlach, S. Ogawa, J. Maciejewski   +36 more
semanticscholar   +1 more source

Recursive Partitioning to Differentiate Acquired From Inherited Bone Marrow Failure Syndromes

American Journal of Hematology, Volume 100, Issue 11, Page 1983-1992, November 2025.
ABSTRACT Distinguishing inherited bone marrow failure (IBMF) from acquired aplastic anemia (aAA) at diagnosis is a major clinical challenge and is essential for appropriate treatment and patients' counseling. Genetic testing to exclude IBMF is frequently subject to delays of several months and may not be available in all centers and could not be ...
Eléonore Kaphan, Anouk Walter‐Petrich, Lise Larcher, Thierry Leblanc, Benedicte Bruno, Edouard Forcade, Cecile Renard, Arthur Sterin, Michael Loschi, Elodie Lainey, Jean Soulier, Caroline Kannengiesser, Gérard Socié, Régis Peffault de Latour, Mony Fahd, Jérome Lambert, Flore Sicre De Fontbrune   +16 more
wiley   +1 more source

Deciphering clinical features and treatment patterns of thrombocytopenic myelodysplastic syndromes. [PDF]

Ann Hematol
Galli N, Pettine L, Croci G, Passamonti F, Barcellini W, Fattizzo B.   +5 more
europepmc   +1 more source

Cytogenetic study of 50 Brazilian patients with primary myelodysplastic syndrome

, 1997
Teresa de Souza Fernandez, Maria Luíza M. Silva, Jamison Menezes de Souza, Daniel Tabak, Eliana Abdelhay   +4 more
openalex   +1 more source